The way in which the US Medicare program pays for drugs administered in physician offices is a relic of the past. Quirks of the law allow practices to capture a significant portion of this revenue stream, and politicians are once again trying to bring these costs under control.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,